Processes of preparing estolide compounds that include removing sulfonate residues

US9346900B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9346900-B2
Application numberUS-201514705729-A
CountryUS
Kind codeB2
Filing dateMay 6, 2015
Priority dateJun 18, 2012
Publication dateMay 24, 2016
Grant dateMay 24, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are processes of preparing sulfonated estolide compounds, and the removal of sulfonate residues from those compounds to provide desulfonated estolide base oils. Exemplary sulfonated estolide compounds include those selected from the formula: wherein z is an integer selected from 0 to 15; q is an integer selected from 0 to 15; x is, independently for each occurrence, an integer selected from 0 to 20; y is, independently for each occurrence, an integer selected 0 to 20; n is equal to or greater than 0; R 6 is selected from —OH, optionally substituted alkyl, and optionally substituted aryl; and R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, wherein each fatty acid chain residue of said compounds is independently optionally substituted.

First claim

Opening claim text (preview).

The invention claimed is: 1. At least one compound of Formula I: wherein W 1 , W 2 , W 3 , W 4 , W 5 , W 6 , and W 7 , independently for each occurrence, are selected from —CH 2 —, —CH═CH—, and —CHR 5 —; Q 1 , Q 2 , and Q 3 , independently for each occurrence, are selected from —CH 3 , —CH═CH 2 , —CH(R 5 )CH 3 , and —CH 2 R 5 , provided that at least one of W 1 , W 2 , W 3 , W 4 , W 5 , W 6 , or W 7 is —CHR 5 —, or at least one of Q 1 , Q 2 , or Q 3 is —CH 2 R 5 ; R 5 , independently for each occurrence, is selected from —OS(O) 2 R 6 , wherein R 6 is selected from —OH, optionally substituted alkyl, and optionally substituted aryl; z is an integer selected from 0 to 15; p is an integer selected from 0 to 15; q is an integer selected from 0 to 15; x is, independently for each occurrence, an integer selected from 0 to 20; y is, independently for each occurrence, an integer selected from 0 to 20; n is equal to or greater than 0; and R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, wherein each fatty acid chain residue of said at least one compound is independently optionally substituted. 2. The at least one compound according to claim 1 , wherein x is, independently for each occurrence, an integer selected from 1 to 10; y is, independently for each occurrence, an integer selected from 1 to 10; n is an integer selected from 0 to 8; and R 2 is an optionally substituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched, wherein each fatty acid chain residue is unsubstituted. 3. The at least one compound according to claim 1 , wherein x is, independently for each occurrence, an integer selected from 7 and 8. 4. The at least one compound according to claim 3 , wherein y is, independently for each occurrence, an integer selected from 7 and 8. 5. The at least one compound according to claim 1 , wherein R 2 is an unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched. 6. The at least one compound according to claim 5 , wherein R 2 is selected from C 6 to C 12 alkyl. 7. The at least one compound according to claim 6 , wherein R 2 is saturated. 8. The at least one compound according to claim 6 , wherein R 2 is branched. 9. The at least one compound according to claim 1 , wherein at least one of W 1 , W 2 , or W 3 is —CHR 5 —. 10. The at least one compound according to claim 1 , wherein R 6 , independently for each occurrence, is selected from optionally substituted alkyl. 11. The at least one compound according to claim 10 , wherein R 6 , independently for each occurrence, is selected from unsubstituted alkyl. 12. The at least one compound according to claim 1 , wherein the at least one compound is selected from compounds of Formula III: 13. The at least one compound according to claim 12 , wherein z is an integer selected from 7 and 8. 14. The at least one compound according to claim 13 , wherein q is an integer selected from 7 and 8. 15. The at least one compound according to claim 12 , wherein n is an integer selected from 0 to 12. 16. The at least one compound according to claim 12 , wherein R 6 is —OH. 17. The at least one compound according to claim 12 , wherein q is 0. 18. The at least one compound according to claim 12 , wherein R 6 , independently for each occurrence, is selected from optionally substituted alkyl. 19. The at least one compound according to claim 18 , wherein R 6 , independently for each occurrence, is selected from unsubstituted alkyl. 20. The at least one compound according to claim 12 , wherein R 6 , independently for each occurrence, is selected from optionally substituted aryl.

Assignees

Inventors

Classifications

  • Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups · CPC title

  • by hydrogenation of unsaturated carbon-to-carbon bonds · CPC title

  • of sulfonic acids or halides thereof · CPC title

  • by isomerisation {(isomerisation induced by hydrogenation C11C3/12)} · CPC title

  • by elimination of functional groups containing oxygen only in singly bound form · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9346900B2 cover?
Provided herein are processes of preparing sulfonated estolide compounds, and the removal of sulfonate residues from those compounds to provide desulfonated estolide base oils. Exemplary sulfonated estolide compounds include those selected from the formula: wherein z is an integer selected from 0 to 15; q is an integer selected from 0 to 15; x is, independently for ea…
Who is the assignee on this patent?
Biosynthetic Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C11C3/006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).